<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: A less costly <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance method for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is desirable </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to compare nonendoscopic balloon cytology with biopsy and brush cytology for detecting <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0002038'>carcinoma</z:mp> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Patients in a surveillance program underwent balloon cytology before endoscopy with biopsy and brush cytology </plain></SENT>
<SENT sid="3" pm="."><plain>Results of cytology were compared with those of histology </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Adequate columnar epithelium was obtained in 52 of 63 (83%) patients with balloon cytology and 59 of 61 (97%) with brush cytology </plain></SENT>
<SENT sid="5" pm="."><plain>Balloon cytology obtained abnormal cells in 6 of 8 patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, 2 of 2 patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 2 of 8 patients with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>Sensitivity of balloon cytology for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> was 80% but only 25% for low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>No patients without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> had abnormal cells </plain></SENT>
<SENT sid="8" pm="."><plain>Brush cytology was abnormal in <z:hpo ids='HP_0000001'>all</z:hpo> 11 patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> but only 2 of 9 patients with low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (sensitivity, 22%) </plain></SENT>
<SENT sid="9" pm="."><plain>Two of 39 patients without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> had abnormal cells (specificity, 95%) </plain></SENT>
<SENT sid="10" pm="."><plain>Balloon cytology cost was sixfold less than endoscopy with biopsy </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Balloon cytology detected 80% of patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> when sampling was adequate </plain></SENT>
<SENT sid="12" pm="."><plain>Brush cytology data suggest that a more abrasive balloon may improve balloon cytology sensitivity </plain></SENT>
<SENT sid="13" pm="."><plain>The potential cost savings of balloon cytology compared with endoscopic <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> support further studies of this technique </plain></SENT>
</text></document>